ArticleCureus2025
Combined Hamartoma of the Retina and Retinal Pigment Epithelium: A Literature Review and Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a case series of two young patients referred to our Ophthalmology Department with a progressive decrease in visual acuity of their left eye, where multimodal imaging findings led us to the diagnosis of combined hamartoma of the retina and retinal pigment epithelium (CHR-RPE). Based on a literature review, we discuss the different multimodal imaging strategies, differential diagnosis, and management of CHR-RPE, a rare benign congenital lesion that can mimic malignant intraocular tumors. CHR-RPE has a challenging differential diagnosis with entities such as choroidal melanoma, nevus, retinoblastoma, and astrocytoma. A correct diagnosis approach is essential to avoid unnecessary invasive procedures. Multimodal imaging plays a crucial role: Optical coherence tomography (OCT) reveals epiretinal membranes (ERM) and retinal disorganization, and fluorescein angiography (FA) demonstrates vascular tortuosity and leakage in advanced disease. Management is usually conservative with strict follow-up. Surgical intervention, including vitrectomy and membrane peeling, remains controversial due to the risk of damaging dysplastic retina. Reported outcomes are variable, although selected cases showed visual improvement, particularly when combined with adjunctive enzymatic therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.